118 related articles for article (PubMed ID: 25069442)
1. Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery.
Pulliero A; Marengo B; Fenoglio D; Parodi A; Cereda C; Domenicotti C; Orcesi S; Galli J; Olivieri I; Filaci G; Balottin U; Fazzi E; Izzotti A
Microrna; 2014; 2(3):187-93. PubMed ID: 25069442
[TBL] [Abstract][Full Text] [Related]
2. The Aicardi-Goutières syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload.
Pulliero A; Fazzi E; Cartiglia C; Orcesi S; Balottin U; Uggetti C; La Piana R; Olivieri I; Galli J; Izzotti A
Mutat Res; 2011 Dec; 717(1-2):99-108. PubMed ID: 21524657
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing.
Pulliero A; Marengo B; Longobardi M; Fazzi E; Orcesi S; Olivieri I; Cereda C; Domenicotti C; Balottin U; Izzotti A
Biochem Biophys Res Commun; 2013 Jan; 430(3):957-62. PubMed ID: 23261460
[TBL] [Abstract][Full Text] [Related]
4. Astrocytes, an active player in Aicardi-Goutières syndrome.
Sase S; Takanohashi A; Vanderver A; Almad A
Brain Pathol; 2018 May; 28(3):399-407. PubMed ID: 29740948
[TBL] [Abstract][Full Text] [Related]
5. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome.
Cuadrado E; Jansen MH; Anink J; De Filippis L; Vescovi AL; Watts C; Aronica E; Hol EM; Kuijpers TW
Brain; 2013 Jan; 136(Pt 1):245-58. PubMed ID: 23365100
[TBL] [Abstract][Full Text] [Related]
6. Different mutations in three prime repair exonuclease 1 and ribonuclease H2 genes affect clinical features in Aicardi-Goutieres syndrome.
Izzotti A; Longobardi M; Cartiglia C; Anzuini F; Arrigo P; Fazzi E; Orcesi S; Piana RL; Pulliero A
J Child Neurol; 2012 Jan; 27(1):51-60. PubMed ID: 21862834
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
Cuadrado E; Michailidou I; van Bodegraven EJ; Jansen MH; Sluijs JA; Geerts D; Couraud PO; De Filippis L; Vescovi AL; Kuijpers TW; Hol EM
J Immunol; 2015 Apr; 194(8):3623-33. PubMed ID: 25769924
[TBL] [Abstract][Full Text] [Related]
8. Aicardi-Goutières syndrome: A monogenic type I interferonopathy.
Liu A; Ying S
Scand J Immunol; 2023 Oct; 98(4):e13314. PubMed ID: 37515439
[TBL] [Abstract][Full Text] [Related]
9. DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes.
Giordano AMS; Luciani M; Gatto F; Abou Alezz M; Beghè C; Della Volpe L; Migliara A; Valsoni S; Genua M; Dzieciatkowska M; Frati G; Tahraoui-Bories J; Giliani SC; Orcesi S; Fazzi E; Ostuni R; D'Alessandro A; Di Micco R; Merelli I; Lombardo A; Reijns MAM; Gromak N; Gritti A; Kajaste-Rudnitski A
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35262626
[TBL] [Abstract][Full Text] [Related]
10. Bilateral striatal necrosis in two subjects with Aicardi-Goutières syndrome due to mutations in ADAR1 (AGS6).
La Piana R; Uggetti C; Olivieri I; Tonduti D; Balottin U; Fazzi E; Orcesi S
Am J Med Genet A; 2014 Mar; 164A(3):815-9. PubMed ID: 24376015
[TBL] [Abstract][Full Text] [Related]
11. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans.
White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F
Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507
[TBL] [Abstract][Full Text] [Related]
12. Genome instability consequences of RNase H2 Aicardi-Goutières syndrome alleles.
Potenski CJ; Epshtein A; Bianco C; Klein HL
DNA Repair (Amst); 2019 Dec; 84():102614. PubMed ID: 30975634
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory myopathy in a patient with Aicardi-Goutières syndrome.
Tumienė B; Voisin N; Preikšaitienė E; Petroška D; Grikinienė J; Samaitienė R; Utkus A; Reymond A; Kučinskas V
Eur J Med Genet; 2017 Mar; 60(3):154-158. PubMed ID: 28089741
[TBL] [Abstract][Full Text] [Related]
14. Aicardi-Goutieres syndrome: from patients to genes and beyond.
Chahwan C; Chahwan R
Clin Genet; 2012 May; 81(5):413-20. PubMed ID: 22149989
[TBL] [Abstract][Full Text] [Related]
15. Mutations in RNU7-1 Weaken Secondary RNA Structure, Induce MCP-1 and CXCL10 in CSF, and Result in Aicardi-Goutières Syndrome with Severe End-Organ Involvement.
Naesens L; Nemegeer J; Roelens F; Vallaeys L; Meuwissen M; Janssens K; Verloo P; Ogunjimi B; Hemelsoet D; ; Hoste L; Roels L; De Bruyne M; De Baere E; Van Dorpe J; Dendooven A; Sieben A; Rice GI; Kerre T; Beyaert R; Uggenti C; Crow YJ; Tavernier SJ; Maelfait J; Haerynck F
J Clin Immunol; 2022 Jul; 42(5):962-974. PubMed ID: 35320431
[TBL] [Abstract][Full Text] [Related]
16. Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5.
Onizawa H; Kato H; Kimura H; Kudo T; Soda N; Shimizu S; Funabiki M; Yagi Y; Nakamoto Y; Priller J; Nishikomori R; Heike T; Yan N; Tsujimura T; Mimori T; Fujita T
Int Immunol; 2021 Mar; 33(4):225-240. PubMed ID: 33165593
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
[TBL] [Abstract][Full Text] [Related]
18. Aicardi-Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies.
Cuadrado E; Vanderver A; Brown KJ; Sandza A; Takanohashi A; Jansen MH; Anink J; Herron B; Orcesi S; Olivieri I; Rice GI; Aronica E; Lebon P; Crow YJ; Hol EM; Kuijpers TW
Ann Rheum Dis; 2015 Oct; 74(10):1931-9. PubMed ID: 24906636
[TBL] [Abstract][Full Text] [Related]
19. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
Fisher AJ; Beal PA
RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
[TBL] [Abstract][Full Text] [Related]
20. Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?
Fazzi E; Cattalini M; Orcesi S; Tincani A; Andreoli L; Balottin U; De Simone M; Fredi M; Facchetti F; Galli J; Giliani S; Izzotti A; Meini A; Olivieri I; Plebani A
Autoimmun Rev; 2013 Feb; 12(4):506-9. PubMed ID: 22940555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
